1. Home
  2. KRKR vs SILO Comparison

KRKR vs SILO Comparison

Compare KRKR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

HOLD

Current Price

$4.24

Market Cap

9.2M

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.41

Market Cap

8.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRKR
SILO
Founded
2010
2010
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Apparel
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRKR
SILO
Price
$4.24
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.3K
132.6K
Earning Date
09-26-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,966,526.00
$72,102.00
Revenue This Year
$182.55
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$0.36
52 Week High
$21.36
$3.37

Technical Indicators

Market Signals
Indicator
KRKR
SILO
Relative Strength Index (RSI) 34.20 36.44
Support Level $4.25 $0.42
Resistance Level $4.80 $0.46
Average True Range (ATR) 0.25 0.02
MACD -0.02 0.00
Stochastic Oscillator 13.22 2.22

Price Performance

Historical Comparison
KRKR
SILO

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: